|
1
|
Ferenci P, Lockwood A, Mullen K, Tarter R,
Weissenborn K and Blei AT: Hepatic encephalopathy - definition,
nomenclature, diagnosis, and quantification: Final report of the
working party at the 11th World Congresses of Gastroenterology,
Vienna, 1998. Hepatology. 35:716–721. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cichoż-Lach H and Michalak A: Current
pathogenetic aspects of hepatic encephalopathy and noncirrhotic
hyperammonemic encephalopathy. World J Gastroenterol. 19:26–34.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Patel D, McPhail MJ, Cobbold JF and
Taylor-Robinson SD: Hepatic encephalopathy. Br J Hosp Med (Lond).
73:79–85. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Atluri DK, Prakash R and Mullen KD:
Pathogenesis, diagnosis, and treatment of hepatic encephalopathy. J
Clin Exp Hepatol. 1:77–86. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Häussinger D, Kircheis G, Fischer R,
Schliess F and vom Dahl S: Hepatic encephalopathy in chronic liver
disease: A clinical manifestation of astrocyte swelling and
low-grade cerebral edema? J Hepatol. 32:1035–1038. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wilson JX: Antioxidant defense of the
brain: A role for astrocytes. Can J Physiol Pharmacol.
75:1149–1163. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Henn FA and Hamberger A: Glial cell
function: Uptake of transmitter substances. Proc Natl Acad Sci USA.
68:2686–2690. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Torgner I and Kvamme E: Synthesis of
transmitter glutamate and the glial-neuron interrelationship. Mol
Chem Neuropathol. 12:11–17. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Adams RD and Foley JM: The neurological
disorder associated with liver disease. Res Publ Assoc Res Nerv
Ment Dis. 32:198–237. 1953.PubMed/NCBI
|
|
10
|
Tapper EB, Jiang ZG and Patwardhan VR:
Refining the ammonia hypothesis: A physiology-driven approach to
the treatment of hepatic encephalopathy. Mayo Clin Proc.
90:646–658. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ghabril M, Zupanets IA, Vierling J, Mantry
P, Rockey D, Wolf D, O'Shea R, Dickinson K, Gillaspy H, Norris C,
et al: Glycerol phenylbutyrate in patients with cirrhosis and
episodic hepatic encephalopathy: A pilot study of safety and effect
on venous ammonia concentration. Clin Pharmacol Drug Dev.
2:278–284. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee B, Rhead W, Diaz GA, Scharschmidt BF,
Mian A, Shchelochkov O, Marier JF, Beliveau M, Mauney J and
Dickinson K: Phase 2 comparison of a novel ammonia scavenging agent
with sodium phenylbutyrate in patients with urea cycle disorders:
Safety, pharmacokinetics and ammonia control. Mol Genet Metab.
100:221–228. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rahimi RS and Rockey DC: Hepatic
encephalopathy: Pharmacological therapies targeting ammonia. Semin
Liver Dis. 36:48–55. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bass NM, Mullen KD, Sanyal A, Poordad F,
Neff G, Leevy CB, Sigal S, Sheikh MY, Beavers K, Frederick T, et
al: Rifaximin treatment in hepatic encephalopathy. N Engl J Med.
362:1071–1081. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mozdziak PE, Pophal S, Borwornpinyo S and
Petitte JN: Transgenic chickens expressing beta-galactosidase
hydrolyze lactose in the intestine. J Nutr. 133:3076–3079. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Haemmerli UP, Kistler H, Ammann R,
Marthaler T, Semenza G, Auricchio S and Prader A: Acquired milk
intolerance in the adult caused by lactose malabsorption due to a
selective deficiency of intestinal lactase activity. Am J Med.
38:7–30. 1965. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bircher J, Müller J, Guggenheim P and
Haemmerli UP: Treatment of chronic portal-systemic encephalopathy
with lactulose. Lancet. 1:890–892. 1966.PubMed/NCBI
|
|
18
|
Rahimi RS, Singal AG, Cuthbert JA and
Rockey DC: Lactulose vs polyethylene glycol 3350 - electrolyte
solution for treatment of overt hepatic encephalopathy: The HELP
randomized clinical trial. JAMA Intern Med. 174:1727–1733. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Piechota M: Hepatic encephalopathy in the
course of alcoholic liver disease - treatment options in the
intensive care unit. Anaesthesiol Intensive Ther. 46:34–36. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang F, Ren C, Zhao H, Yang L, Su F, Zhou
MM, Han J, Sobie EA and Walsh MJ: Identification of novel
prognostic indicators for triple-negative breast cancer patients
through integrative analysis of cancer genomics data and protein
interactome data. Oncotarget. 7:71620–71634. 2016.PubMed/NCBI
|
|
21
|
Wu CH, Hsu CL, Lu PC, Lin WC, Juan HF and
Huang HC: Identification of lncRNA functions in lung cancer based
on associated protein-protein interaction modules. Sci Rep.
6:359392016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen L, Huang T, Zhang YH, Jiang Y, Zheng
M and Cai YD: Identification of novel candidate drivers connecting
different dysfunctional levels for lung adenocarcinoma using
protein-protein interactions and a shortest path approach. Sci Rep.
6:298492016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hollander D, Donyo M, Atias N, Mekahel K,
Melamed Z, Yannai S, Lev-Maor G, Shilo A, Schwartz S, Barshack I,
et al: A network-based analysis of colon cancer splicing changes
reveals a tumorigenesis-favoring regulatory pathway emanating from
ELK1. Genome Res. 26:541–553. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang D, Chen P, Zheng CH and Xia J:
Identification of ovarian cancer subtype-specific network modules
and candidate drivers through an integrative genomics approach.
Oncotarget. 7:4298–4309. 2016.PubMed/NCBI
|
|
25
|
Azevedo H and Moreira-Filho CA:
Topological robustness analysis of protein interaction networks
reveals key targets for overcoming chemotherapy resistance in
glioma. Sci Rep. 5:168302015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Feser WJ, Fingerlin TE, Strand MJ and
Glueck DH: Calculating average power for the Benjamini-Hochberg
procedure. J Stat Theory Appl. 8:325–352. 2009.PubMed/NCBI
|
|
27
|
Butterworth RF: Hepatic encephalopathy - a
serious complication of alcoholic liver disease. Alcohol Res
Health. 27:143–145. 2003.PubMed/NCBI
|
|
28
|
Córdoba J, García-Martinez R and
Simón-Talero M: Hyponatremic and hepatic encephalopathies:
Similarities, differences and coexistence. Metab Brain Dis.
25:73–80. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ortiz M, Jacas C and Córdoba J: Minimal
hepatic encephalopathy: Diagnosis, clinical significance and
recommendations. J Hepatol. 42 Suppl:S45–S53. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fedorova OA, Moiseeva TN, Nikiforov AA,
Tsimokha AS, Livinskaya VA, Hodson M, Bottrill A, Evteeva IN,
Ermolayeva JB, Kuznetzova IM, et al: Proteomic analysis of the 20S
proteasome (PSMA3)-interacting proteins reveals a functional link
between the proteasome and mRNA metabolism. Biochem Biophys Res
Commun. 416:258–265. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sjakste T, Paramonova N, Rumba-Rozenfelde
I, Trapina I, Sugoka O and Sjakste N: Juvenile idiopathic arthritis
subtype- and sex-specific associations with genetic variants in the
PSMA6/PSMC6/PSMA3 gene cluster. Pediatr Neonatol. 55:393–403. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Smith DM, Fraga H, Reis C, Kafri G and
Goldberg AL: ATP binds to proteasomal ATPases in pairs with
distinct functional effects, implying an ordered reaction cycle.
Cell. 144:526–538. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Song M, Wang Y, Zhang Z and Wang S: PSMC2
is up-regulated in osteosarcoma and regulates osteosarcoma cell
proliferation, apoptosis and migration. Oncotarget. 8:933–953.
2017.PubMed/NCBI
|
|
34
|
García J: The calcium channel α2/δ1
subunit interacts with ATP5b in the plasma membrane of developing
muscle cells. Am J Physiol Cell Physiol. 301:C44–C52. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Geyik E, Igci YZ, Pala E, Suner A, Borazan
E, Bozgeyik I, Bayraktar E, Bayraktar R, Ergun S, Cakmak EA, et al:
Investigation of the association between ATP2B4 and ATP5B genes
with colorectal cancer. Gene. 540:178–182. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Panaretou B, Siligardi G, Meyer P, Maloney
A, Sullivan JK, Singh S, Millson SH, Clarke PA, Naaby-Hansen S,
Stein R, et al: Activation of the ATPase activity of hsp90 by the
stress-regulated cochaperone aha1. Mol Cell. 10:1307–1318. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shao J, Wang L, Zhong C, Qi R and Li Y:
AHSA1 regulates proliferation, apoptosis, migration, and invasion
of osteosarcoma. Biomed Pharmacother. 77:45–51. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Visweswaraiah J, Pittman Y, Dever TE and
Hinnebusch AG: The β-hairpin of 40S exit channel protein Rps5/uS7
promotes efficient and accurate translation initiation in vivo.
eLife. 4:e079392015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Pizzuti A, Gennarelli M, Novelli G,
Colosimo A, Lo Cicero S, Caskey CT and Dallapiccola B: Human
elongation factor EF-1 beta: Cloning and characterization of the
EF1 beta 5a gene and assignment of EF-1 beta isoforms to
chromosomes 2,5,15 and X. Biochem Biophys Res Commun. 197:154–162.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sanders J, Maassen JA, Amons R and Möller
W: Nucleotide sequence of human elongation factor-1 beta cDNA.
Nucleic Acids Res. 19:45511991. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chambers DM, Rouleau GA and Abbott CM:
Comparative genomic analysis of genes encoding translation
elongation factor 1B(alpha) in human and mouse shows EEF1B1 to be a
recent retrotransposition event. Genomics. 77:145–148. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
de Coo R, Buddiger P, Smeets H, van Kessel
Geurts A, Morgan-Hughes J, Weghuis DO, Overhauser J and van Oost B:
Molecular cloning and characterization of the active human
mitochondrial NADH:ubiquinone oxidoreductase 24-kDa gene (NDUFV2)
and its pseudogene. Genomics. 26:461–466. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chen T, Wu Q, Zhang Y and Zhang D: NDUFV2
regulates neuronal migration in the developing cerebral cortex
through modulation of the multipolar-bipolar transition. Brain Res.
1625:102–110. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Washizuka S, Iwamoto K, Kazuno AA,
Kakiuchi C, Mori K, Kametani M, Yamada K, Kunugi H, Tajima O,
Akiyama T, et al: Association of mitochondrial complex I subunit
gene NDUFV2 at 18p11 with bipolar disorder in Japanese and the
National Institute of Mental Health pedigrees. Biol Psychiatry.
56:483–489. 2004. View Article : Google Scholar : PubMed/NCBI
|
